|
SP4 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.64519509127103E-11 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.15969505904468E-11 |
| Normal-vs-Stage2 |
1.68889999985211E-07 |
| Normal-vs-Stage3 |
6.00053340349405E-12 |
| Normal-vs-Stage4 |
2.27928786955545E-13 |
| Stage1-vs-Stage2 |
6.900800E-01 |
| Stage1-vs-Stage3 |
1.499010E-01 |
| Stage1-vs-Stage4 |
7.962300E-03 |
| Stage2-vs-Stage3 |
1.971830E-01 |
| Stage2-vs-Stage4 |
4.317700E-02 |
| Stage3-vs-Stage4 |
2.536400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.35319533356437E-11 |
| Normal-vs-AfricanAmerican |
1.566460E-04 |
| Normal-vs-Asian |
3.30040439422419E-11 |
| Caucasian-vs-AfricanAmerican |
1.879810E-01 |
| Caucasian-vs-Asian |
5.267400E-01 |
| AfricanAmerican-vs-Asian |
1.154580E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.87889720343537E-12 |
| Normal-vs-Female |
3.80789844101059E-11 |
| Male-vs-Female |
2.311000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.33679955993671E-10 |
| Normal-vs-Age(41-60Yrs) |
1.88737914186277E-15 |
| Normal-vs-Age(61-80Yrs) |
7.95064014624813E-12 |
| Normal-vs-Age(81-100Yrs) |
1.120550E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.197800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.070400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.824200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.940000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.489400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.518400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.041470E-04 |
| Classical-VS-Follicular |
6.164800E-01 |
| Classical-VS-Other |
2.567600E-01 |
| Classical-VS-Normal |
4.42839986902754E-10 |
| Tall-VS-Follicular |
5.717900E-03 |
| Tall-VS-Other |
6.752400E-01 |
| Tall-VS-Normal |
1.68165481539972E-12 |
| Follicular-VS-Other |
4.113600E-01 |
| Follicular-VS-Normal |
1.31029964656193E-10 |
| Other-VS-Normal |
6.010000E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.88178419700125E-16 |
| Normal-vs-N1 |
4.01301214481009E-12 |
| N0-vs-N1 |
1.058220E-01 |
|
|
